Brian MacDonald

Brian is the founding CEO of Disc Medicine and has founded two companies engaged in the discovery and development of hepcidin-targeting therapeutics. Prior to Disc Medicine he was the Founder and CEO of Merganser Biotech working on minihepcidin peptides. He has 25 years of drug development and executive management experience in a range of different therapeutic areas at companies that include Zelos Therapeutics, 3-Dimensional Pharmaceuticals and GlaxoSmithKline. He is a research physician with an academic and clinical background in musculoskeletal biology and rheumatology. He received his MB, ChB and PhD from the University of Sheffield and is a Member of the Royal College of Physicians.